Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$3.2 - $5.69 $3.7 Million - $6.59 Million
1,157,500 New
1,157,500 $5.43 Million

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Owl Creek Asset Management, L.P. Portfolio

Follow Owl Creek Asset Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Owl Creek Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Owl Creek Asset Management, L.P. with notifications on news.